drugset / Trial / NCT03357731

A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function

NCT03357731

Phase 2 Completed 49 enrolled Bristol-Myers Squibb
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to evaluate the effects of BMS-986231 on systolic and diastolic parameters in patients with heart failure and low ejection fraction.

Timeline

Start
2017-11-30
Primary completion
2019-05-10
Completion
2019-05-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitroglycerin Unknown
Subject cimlanod Other / unclassified Intravenous